Headache is among the most frequent symptoms persisting or newly developing after
coronavirus disease 2019 (COVID-19) as part of the so-called long COVID syndrome. The …

Background The mechanisms by which any upper respiratory virus, including SARS-CoV-2,
impairs chemosensory function are not known. COVID-19 is frequently associated with …

Background An unknown proportion of people who had an apparently mild COVID-19
infection continue to suffer with persistent symptoms, including chest pain, shortness of …

Neurological complications are common in COVID-19. Although SARS-CoV-2 has been
detected in patients' brain tissues, its entry routes and resulting consequences are not well …

Objectives “Long COVID”, a term coined by COVID-19 survivors, describes persistent or new
symptoms in a subset of patients who have recovered from acute illness. Globally, the …

Background The spectrum of neurological and psychiatric complications associated with
paediatric SARS-CoV-2 infection is poorly understood. We aimed to analyse the range and …

Abstract Currently, SARS-CoV-2 has caused a global pandemic and threatened many lives.
Although SARS-CoV-2 mainly causes respiratory diseases, growing data indicate that SARS …

Background The general medical impacts of coronavirus (COVID‐19) are increasingly
appreciated. However, its impact on neurocognitive, psychiatric health and quality of life …

Abstract Background The SARS-CoV-2 pandemic is currently leading to increasing numbers
of COVID-19 patients all over the world. Clinical presentations range from asymptomatic …

Objective To determine the prevalence and associated mortality of well-defined neurologic
diagnoses among patients with coronavirus disease 2019 (COVID-19), we prospectively …